Carlyle Group Inc.

WASHINGTON, DC · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 6, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$8.36B2026 Q3
Positions16
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%

Carlyle Group Inc. reported 16 positions worth $8.36B as of September 30, 2026 (13F filed November 6, 2026). Largest holding: MDLN (77.6%).

10 / 16 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 MDLNMedline$6.49B77.64%187,083,713——+12.9%
▸ 2 SAROStandardAero$1.81B21.60%84,587,035——+28.4%
▸ 3 PHATPhathom Pharmaceuticals$25.5M0.30%3,496,808——-17.0%
▸ 4 PONYPony AI$15.5M0.18%2,362,447——-35.8%
▸ 5 INVHInvitation Homes$12.6M0.15%477,500——+1.2%
▸ 6 SPRBSpruce Biosciences$1.9M0.02%38,620———
▸ 7 FWRDForward Air$1.6M0.02%107,214———
▸ 8 ACETAdicet Bio$1.3M0.02%184,295———
▸ 9 HOODRobinhood Markets$986.3K0.01%8,767——-35.9%
▸ 10 DNUTKrispy Kreme$977.9K0.01%340,748———

Pro Feature

The remaining 6 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Carlyle Group Inc. hold as of Q3 2026?

Carlyle Group Inc. reported 16 positions worth $8.36B in its Q3 2026 13F filing. Largest positions: MDLN (77.6%), SARO (21.6%), PHAT (0.3%), PONY (0.2%) and INVH (0.1%).

What did Carlyle Group Inc. buy in Q3 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Carlyle Group Inc. sell in Q3 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.